IndraLab

Statements


1 | 21

reach
"Tofacitinib suppresses Spike protein potentiated STAT1 signaling, whereas this function was unchanged by TNFi."

reach
"Tofacitinib and ruxolitinib suppress STAT1 activation in TNF-stimulated RA synovial macrophages (41)."

reach
"Both tocilizumab and tofacitinib fully inhibited pSTAT3 (p<0.0001) and pSTAT1 (p<0.0001), both of which are induced by IL-6 ( Figures 3E, F )."

reach
"Inhibition of STAT1 by tofacitinib could aid in producing the anti-inflammatory function in RA [73]."

reach
"Tofacitinib blocks IFN signalling by inhibiting STAT1 activation and has been effective in treating these two conditions ."

reach
"At the maximum oral dose tested (i.e., 60mg/kg), tofacitinib inhibited pSTAT1 elevation by 74 +/-12% (mean +/-SEM)."

reach
"XREF_BIBR In this study, tofacitinib inhibited pSTAT1, pSTAT3 and NFkappaBp65 in PsAFLS and PsA explants, an effect that was paralleled by induction of both SOCS3 and PIAS3."

reach
"Gao et al. [XREF_BIBR] have administered tofacitinib to synovial cells obtained from patients with psoriatic arthritis and found that tofacitinib statistically significant inhibited STAT3 and STAT1, in addition to stimulating suppressor of cytokine signaling 3 (SOCS3) and protein inhibitor of activated STAT3 (PIAS3)."

reach
"This result indicates that tofacitinib may be able to suppress IFN-γ signaling via inhibition of JAK1/STAT1 pathway.In this study, we revealed that topical application of tofacitinib suppressed cornea[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"Tofacitinib was also shown to inhibit STAT1, STAT3, STAT4, STAT5 and STAT6 activation in cultured anti-CD3-stimulated T cells, which suggests that targeting the cytokine signalling pathway with TKIs may be a consideration for immunosuppression 183."

reach
"1muM of Ruxolitinib (JAK1/2 inhibitor) and 5muM of Tofacitinib (JAK1/3 inhibitor) suppressed the IL-27-mediated STAT-1, -3 and -5 activation (XREF_SUPPLEMENTARY) without any significant change in cell viability (data not shown)."

reach
"The authors reported that tofacitinib inhibited pSTAT1 in tofacitinib sensitive UC organoids, but not in organoids insensitive to tofacitinib."

reach
"In addition, tofacitinib suppressed M1 macrophage polarization via STAT1 activation after IFN-γ and lipopolysaccharide stimulation in vitro."

reach
"Tofacitinib could suppress M1 macrophage polarization and subsequently delay CGR by inhibiting STAT1 activation."

reach
"Tofacitinib inhibited pSTAT1 and pSTAT3, with no effect on tSTAT1 or tSTAT3 compared with DMSO control (XREF_FIG B, D), pSTAT2 was undetectable."

reach
"Tofacitinib is new agent, a selective inhibitor of Janus kinase (JAK) signaling pathways mediated by JAK1 and JAK3 and inhibits the key transcription factors STAT1 and STAT3."

reach
"They demonstrated that tofacitinib significantly decreased Signal Transducer and Activator of Transcription (STAT) 3, pSTAT1, Nuclear Factor (NF) kappaBp65 and induced Suppressor of Cytokine Signaling (SOCS) 53 and Protein Inhibitor Of Activated STAT (PIAS) 3 expression in the cells and explant cultures."

reach
"Inhibition of pSTAT1 by tofacitinib accounts for the early improvement of experimental chronic synovitis."

reach
"Tofacitinib downregulated both p-STAT1 and p-STAT3 to control levels."

reach
"Tofacitinib inhibits STAT-1 activation, resulting in the downregulation of IL-6 and IFN-γ in naïve CD4 T cells (31)."

reach
"Through its ability to inhibit JAK1 activity, tofacitinib is able to block the activation of STAT3 and STAT1 downstream of IL-6 and STAT1 but not STAT4 activation downstream of IL-12 even at a high concentration of the inhibitor (500nM in vitro) [XREF_BIBR] In summary these changes are associated with a reduction in mouse Th1 and Th2 polarization and a reduction in the expression of inflammatory cytokines from both T cells and cells of the innate immune system [XREF_BIBR]."